AVTR News | Roxom Stocks

Invest Private Security Newsroom

Market Overview

Indices and commodities.

Bitcoin treasury preferreds.

The artificial intelligence theme.

Bitcoin Treasuries

Companies holding bitcoin.

Sectors, global markets and rates.

Popular Portfolios

13F filings, smart money.

Borrow USDT or USDC against your BTC without giving it up.

Switch your bitcoin-backed loan and pay less interest.

Borrow, invest, keep the spread.

Stock Dividends

Dividends from tokenized equities.

Company

Our leadership team, mission, and investors.

Vision, purpose, and architecture behind Roxom.

Terms, privacy, and disclosures.

Resources

Guides, FAQs & support.

Trading logic, platform rules, and fundamentals.

Connect, authenticate, and build with our API.

Current platform health and incidents.

Loading chart

Pay with

1 BTC

=

- USD

Loading market data...

Loading chart

Pay with

AV

Mkt Cap

$11.10B

Volume

17.14M

Next Earnings

October 28th

Loading chart

AV

AVTRAvantor, Inc.

AVTR

Pay with—

Available Balance0.00

AV

Mkt Cap

$10.88B

Volume

17.14M

Next Earnings

October 28th

Chart Financials Earnings News About Insider Filings

Here's Why You Should Add Avantor Stock to Your Portfolio for NowAvantor (AVTR) reported strong second-quarter 2026 results with raised 2026 guidance, driven by VWR segment's return to 1.7% organic growth and BMP's double-digit order growth. However, BMP's continued 5.6% organic revenue decline and uneven demand recovery remain concerns. The company's Revival program shows execution improvements across commercial performance and operations.Zacks Investment Research · Oct 13, 2026

Progyny (PGNY) Soars 6.3%: Is Further Upside Left in the Stock?Progyny (PGNY) shares surged 6.3% following positive insights from its annual selling season, with the company expecting to add 1.2 million new covered lives through the first half of 2027. The fertility benefits provider is projected to report quarterly earnings of $0.51 per share (+13.3% YoY) and revenues of $339.72 million (+8.4% YoY). However, unchanged earnings estimate revisions over the past 30 days suggest the recent rally may lack sustained momentum.Zacks Investment Research · Oct 8, 2026

VTRS vs. AVTR: Which Stock Is the Better Value Option?A comparison of two Medical Services sector stocks, Viatris (VTRS) and Avantor (AVTR), both holding a Zacks Rank #2 (Buy) rating. Based on valuation metrics including forward P/E ratio (7.01 vs 19.51), PEG ratio (1.92 vs 11.93), and P/B ratio (1.44 vs 1.9), Viatris emerges as the superior value opportunity with a Value grade of A compared to Avantor's C grade.Zacks Investment Research · Oct 6, 2026

Global Methyl Grignard Reagent Market - Strategic Forecast, 2026-2032 | Pharmaceutical Demand, AI Process Control, and Resilient Supply Chains Unlock Growth OpportunitiesThe global methyl Grignard reagent market is experiencing growth driven by pharmaceutical demand, AI-enabled process control, and resilient supply chains. The market emphasizes safety, quality consistency, and reliable supply across regions, with AI tools improving research and manufacturing operations while maintaining expert oversight. Regional strategies vary based on local infrastructure, regulatory requirements, and technical capabilities.GlobeNewswire Inc. · Oct 5, 2026

Avantor Broadens RIM Single-Use Bioprocessing Reach in APACAvantor has expanded its RIM single-use bioprocessing portfolio across the Asia Pacific region with local manufacturing in China. The expansion aims to improve supply reliability and customization for regional biopharma customers. The company's Bioscience & Medtech Products segment showed double-digit order growth and a 1.1x book-to-bill ratio in Q2 2026, supporting long-term bioprocessing growth.Zacks Investment Research · Sep 18, 2026

EXCLUSIVE: Petrochemical Crunch From Iran War Isn't Hitting Hospitals Yet—But Analysts Say Costs For Critical Medical Supplies Could Rise Within WeeksThe Iran-Israel conflict and potential Strait of Hormuz disruption are creating supply chain pressures on medical supplies through petrochemical derivatives. Key inputs like naphtha and methanol used in pharmaceutical packaging and drug synthesis are experiencing price increases. While hospitals haven't yet felt the impact, analysts expect cost pressures on IV bags, tubing, and other critical consumables to surface within 2-4 weeks as the disruption ripples through supply chains.Benzinga · Mar 25, 2026

Looking For A Rebound? China Tech and Emerging Markets Top Oversold ListMultiple China-focused stocks and emerging market ETFs have fallen into deeply oversold territory with exceptionally low RSI readings, potentially setting up for sharp rebounds if risk sentiment improves. The oversold list is dominated by Chinese internet and tech names alongside broader Asian and emerging market exposures, though investors are cautioned that low RSI alone is not a reliable trading signal.Benzinga · Mar 4, 2026

Avantor Stock Down 46% This Past Year, but One Fund's $23 Million Bet Signals Turnaround PotentialDespite Avantor's stock declining 46% over the past year, Chicago-based Kinney Asset Management increased its position to 1.85 million shares worth $23.03 million, making it the fund's largest holding. The move signals confidence in the company's turnaround potential, as management authorizes a $500 million share repurchase program while the company navigates a reset with softer biopharma demand and a $785 million goodwill impairment.The Motley Fool · Jan 2, 2026

Portnoy Law Firm Announces Class Action on Behalf of Avantor, Inc. InvestorsAvantor, Inc. faces a class action lawsuit alleging that company executives failed to disclose weakening competitive positioning and increased competitive intensity affecting its Laboratory Solutions business. The company cut guidance multiple times in 2025 after reporting weak organic sales growth. Stock prices fell significantly following each earnings announcement (16%, 15%, and 23% declines), with the third quarter results revealing that actual performance was worse than management's recent projections.GlobeNewswire Inc. · Dec 29, 2025

Lost Money on Avantor, Inc.(AVTR)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyLevi & Korsinsky, LLP has filed class action securities lawsuits against Avantor, Inc. (AVTR), Coupang, Inc. (CPNG), and DeFi Technologies (DEFT) alleging securities fraud. Avantor investors claim the company made false statements about its competitive positioning and concealed negative effects from increased competition during March 5, 2024 to October 28, 2025. Investors who suffered losses during the relevant periods can join the lawsuits at no cost.GlobeNewswire Inc. · Dec 26, 2025

to start trading

AV

AVTRAvantor, Inc.

AVTR

Pay with—

Available Balance0.00

Your PositionYou don't own any AVTR yet.

Related Tickers

Earnings